Crinetics Pharmaceuticals Net Profit Margin 2017-2020 | CRNX

Crinetics Pharmaceuticals net profit margin from 2017 to 2020. Net profit margin can be defined as net Income as a portion of total sales revenue.
Crinetics Pharmaceuticals Net Profit Margin Historical Data
Date TTM Revenue TTM Net Income Net Margin
2019-12-31 $0.00B $-0.05B -5000.00%
2019-09-30 $0.00B $-0.04B -2150.00%
2019-03-31 $0.00B $-0.03B -1033.33%
2018-12-31 $0.00B $-0.03B -900.00%
2018-09-30 $0.00B $-0.02B -733.33%
2018-06-30 $0.00B $-0.02B -533.33%
2018-03-31 $0.00B $-0.01B -400.00%
2017-12-31 $0.00B $-0.01B -333.33%
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $0.433B $0.001B
Crinetics Pharmaceuticals Inc is a clinical stage pharmaceutical company. It focuses on the discovery, development and commercialization of novel therapeutics for rare endocrine diseases and endocrine-related tumors. The company's product pipeline consists of CRN00808 for the treatment of Acromegaly, CRN02481 for the treatment of Hyperinsulinemias and CRN01941 for the treatment of Neuroendocrine Tumors which are in clinical stage. Crinetics Pharmaceuticals Inc is based in San Diego, United States.
Stock Name Country Market Cap PE Ratio
Zoetis (ZTS) United States $76.689B 41.80
Takeda Pharmaceutical (TAK) Japan $56.686B 10.58
Astellas Pharma (ALPMY) Japan $26.828B 16.76
Eisai (ESALY) Japan $22.299B 19.43
UCB SA (UCBJF) Belgium $21.755B 0.00
Merck (MKGAF) Germany $20.606B 27.02
Catalent (CTLT) United States $15.773B 47.18
Grifols, S.A (GRFS) Spain $13.235B 15.16
Neurocrine Biosciences (NBIX) United States $8.860B 69.73
Hikma Pharmaceuticals Plc (HKMPF) United Kingdom $8.491B 0.00
Jazz Pharmaceuticals (JAZZ) Ireland $7.974B 12.88
IPSEN SA ADR (IPSEY) France $7.714B 0.00
Ionis Pharmaceuticals (IONS) United States $7.148B 70.03
STADA ARZNEIMI (STDAF) Germany $6.884B 0.00
Arrowhead Pharmaceuticals (ARWR) United States $6.437B 0.00
Orion OYJ (ORINY) Finland $6.272B 21.76
United Therapeutics (UTHR) United States $5.888B 12.53
Evotec AG (EVTCY) Germany $5.150B 350.00
PTC Therapeutics (PTCT) United States $4.285B 0.00
ChemoCentryx (CCXI) United States $3.858B 0.00
Hypermarcas (HYPMY) Brazil $3.781B 13.91
Sage Therapeutics (SAGE) United States $3.781B 0.00
FibroGen (FGEN) United States $3.754B 0.00
Cronos Group (CRON) Canada $2.960B 0.00
Nektar Therapeutics (NKTR) United States $2.955B 0.00
Revolution Medicines (RVMD) United States $2.883B 0.00
Taro Pharmaceutical Industries (TARO) Israel $2.763B 14.10
Corcept Therapeutics (CORT) United States $2.671B 25.83
Pacira BioSciences (PCRX) United States $2.626B 57.02
Xencor (XNCR) United States $2.371B 0.00
Ironwood Pharmaceuticals (IRWD) United States $1.900B 16.26
Trillium Therapeutics (TRIL) Canada $1.884B 0.00
Aurinia Pharmaceuticals Inc (AUPH) Canada $1.854B 0.00
Translate Bio (TBIO) United States $1.654B 0.00
USANA Health Sciences (USNA) United States $1.596B 14.05
Heron Therapeutics (HRTX) United States $1.590B 0.00
Ocular Therapeutix (OCUL) United States $1.282B 0.00
Karyopharm Therapeutics (KPTI) United States $1.245B 0.00
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $1.214B 8.44
Zogenix (ZGNX) United States $1.199B 0.00
Endo (ENDP) Ireland $1.179B 1.79
Theravance Biopharma (TBPH) Cayman Islands $1.102B 0.00
Indivior (INVVY) United States $1.078B 13.36
Tilray (TLRY) Canada $1.078B 0.00
ImmunoGen (IMGN) United States $1.052B 0.00
CLINIGEN GP (CLIGF) United Kingdom $0.942B 0.00
Vectura Group (VEGPF) United Kingdom $0.925B 0.00
Calliditas Therapeutics AB (CALT) Sweden $0.862B 0.00
BioCryst Pharmaceuticals (BCRX) United States $0.860B 0.00
VAXART, INC (VXRT) United States $0.837B 0.00
Enanta Pharmaceuticals (ENTA) United States $0.826B 0.00
Esperion Therapeutics (ESPR) United States $0.793B 0.00
Radius Health (RDUS) United States $0.701B 0.00
Spectrum Pharmaceuticals (SPPI) United States $0.674B 0.00
BioSpecifics Technologies Corp (BSTC) United States $0.650B 33.92
Collegium Pharmaceutical (COLL) United States $0.649B 38.33
Aerie Pharmaceuticals (AERI) United States $0.580B 0.00
Chinook Therapeutics (KDNY) United States $0.575B 0.00
Organogenesis Holdings (ORGO) United States $0.560B 0.00
Flexion Therapeutics (FLXN) United States $0.560B 0.00
Ardelyx (ARDX) United States $0.553B 0.00
Siga Technologies (SIGA) United States $0.539B 15.15
Rigel Pharmaceuticals (RIGL) United States $0.510B 0.00
Altimmune (ALT) United States $0.457B 0.00
Akebia Therapeutics (AKBA) United States $0.450B 0.00
Molecular Templates (MTEM) United States $0.443B 0.00
Innate Pharma SA (IPHYF) France $0.428B 0.00
Avadel Pharmaceuticals (AVDL) Ireland $0.409B 0.00
TherapeuticsMD (TXMD) United States $0.396B 0.00
Profound Medical (PROF) Canada $0.393B 0.00
DURECT (DRRX) United States $0.372B 0.00
Catalyst Pharmaceuticals (CPRX) United States $0.367B 9.57
Harpoon Therapeutics (HARP) United States $0.356B 0.00
Concert Pharmaceuticals (CNCE) United States $0.348B 0.00
KalVista Pharmaceuticals (KALV) United States $0.345B 0.00
Calithera Biosciences (CALA) United States $0.342B 0.00
Rafael Holdings (RFL) United States $0.342B 0.00
MEI Pharma (MEIP) United States $0.324B 0.00
Summit Therapeutics (SMMT) United States $0.322B 0.00
Redhill Biopharma (RDHL) Israel $0.321B 0.00
CASI Pharmaceuticals (CASI) United States $0.299B 0.00
Menlo Therapeutics (VYNE) United States $0.280B 0.00
Jounce Therapeutics (JNCE) United States $0.271B 0.00
Lannett Co Inc (LCI) United States $0.262B 6.91
CTI BioPharma (CTIC) United States $0.246B 0.00
Nature's Sunshine Products (NATR) United States $0.246B 15.81
IMV INC (IMV) Canada $0.244B 0.00
Aquestive Therapeutics (AQST) United States $0.232B 0.00
Otonomy (OTIC) United States $0.231B 0.00
Alpine Immune Sciences (ALPN) United States $0.231B 0.00
Matinas Biopharma Holdings (MTNB) United States $0.211B 0.00
OptiNose (OPTN) United States $0.211B 0.00
Xeris Pharmaceuticals (XERS) United States $0.206B 0.00
Oasmia Pharmaceutical AB (OASMY) Sweden $0.206B 0.00
Heat Biologics (HTBX) United States $0.169B 0.00
Taiwan Liposome (TLC) Taiwan $0.163B 0.00
Aclaris Therapeutics (ACRS) United States $0.151B 0.00
Champions Oncology (CSBR) United States $0.143B 0.00
La Jolla Pharmaceutical (LJPC) United States $0.137B 0.00
AcelRx Pharmaceuticals (ACRX) United States $0.132B 0.00
Infinity Pharmaceuticals (INFI) United States $0.132B 0.00
ProPhase Labs (PRPH) United States $0.125B 0.00
Ayala Pharmaceuticals (AYLA) Israel $0.124B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.122B 0.00
ALLERGY THERAPT (AGYTF) United Kingdom $0.112B 0.00
MediWound (MDWD) Israel $0.100B 0.00
Lipocine (LPCN) United States $0.098B 0.00
Aptorum Group (APM) Hong Kong, SAR China $0.088B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.084B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.081B 0.00
Biomerica (BMRA) United States $0.077B 0.00
Hemispherx BioPharma (AIM) United States $0.075B 0.00
Novan (NOVN) United States $0.075B 0.00
India Globalization Capital (IGC) United States $0.075B 0.00
Nutriband (NTRB) United States $0.074B 0.00
KemPharm (KMPH) United States $0.074B 0.00
ElectroCore (ECOR) United States $0.072B 0.00
SCYNEXIS (SCYX) United States $0.070B 0.00
Onconova Therapeutics (ONTX) United States $0.069B 0.00
Kitov Pharmaceuticals Holdings (KTOV) Israel $0.067B 0.00
AgeX Therapeutics (AGE) United States $0.066B 0.00
GTx (ONCT) United States $0.065B 0.00
Natural Alternatives (NAII) United States $0.065B 125.94
Entasis Therapeutics Holdings (ETTX) United States $0.063B 0.00
CV Sciences (CVSI) United States $0.061B 0.00
Recro Pharma (REPH) United States $0.057B 0.00
Addex Therapeutics (ADXN) Switzerland $0.055B 0.00
Dipexium Pharmaceuticals (PLXP) United States $0.055B 0.00
Forward Pharma (FWP) Denmark $0.048B 0.00
Adamis Pharmaceuticals (ADMP) United States $0.048B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.045B 22.92
ASSERTIO THERAPEUTICS, INC (ASRT) United States $0.044B 0.00
Mannatechorporated (MTEX) United States $0.039B 5.71
Jaguar Animal Health (JAGX) United States $0.037B 0.00
Opiant Pharmaceuticals (OPNT) United States $0.035B 0.00
Vical (BBI) United States $0.034B 0.00
IsoRay (ISR) United States $0.033B 0.00
Neos Therapeutics (NEOS) United States $0.032B 0.00
Iterum Therapeutics (ITRM) Ireland $0.028B 0.00
Can-Fite Biopharma (CANF) Israel $0.028B 0.00
PolarityTE (PTE) United States $0.027B 0.00
Regulus Therapeutics (RGLS) United States $0.027B 0.00
NovaBay Pharmaceuticals (NBY) United States $0.026B 0.00
Midatech Pharma (MTP) United Kingdom $0.022B 0.00
Hancock Jaffe Laboratories (HJLI) United States $0.018B 0.00
Cyanotech (CYAN) United States $0.017B 27.82
Eyegate Pharmaceuticals (EYEG) United States $0.016B 0.00
Bellicum Pharmaceuticals (BLCM) United States $0.016B 0.00
Bio-Path Holdings (BPTH) United States $0.015B 0.00
Flex Pharma (SLRX) United States $0.015B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.014B 0.00
RXi Pharmaceuticals (PHIO) United States $0.014B 0.00
China SXT Pharmaceuticals (SXTC) China $0.012B 0.00
Shineco (TYHT) China $0.010B 0.00
Cytori Therapeutics Inc (PSTV) United States $0.010B 0.00
JanOne (JAN) United States $0.008B 0.00
Xenetic Biosciences (XBIO) United States $0.007B 0.00
CannTrust Holdings (CTST) Canada $0.000B 0.00
Sundial Growers (SNDL) Canada $0.000B 0.00